Safety and Efficacy of Ceftazidime-Avibactam Plus Metronidazole in the Treatment of Children ≥3 Months to <18 Years With Complicated Intra-Abdominal Infection: Results From a Phase 2, Randomized, Controlled Trial-Reference-Cited by-同舟云学术

Safety and Efficacy of Ceftazidime-Avibactam Plus Metronidazole in the Treatment of Children ≥3 Months to <18 Years With Complicated Intra-Abdominal Infection: Results From a Phase 2, Randomized, Controlled Trial

Published:2019-08 Issue:8 Volume:38 Page:816-824
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

Bradley John S.,Broadhurst Helen,Cheng Karen,Mendez Maria,Newell Paul,Prchlik Martin,Stone Gregory G.,Talley Angela K.,Tawadrous Margaret,Wajsbrot Dalia,Yates Katrina,Zuzova Antonina,Gardner Annie

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology, and Child Health

Reference22 articles.

1. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America.;Solomkin;Surg Infect (Larchmt),2010

2. The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections.;Sartelli;World J Emerg Surg,2017

3. Community-acquired complicated intra-abdominal infections in children hospitalized during 1995-2004 at a paediatric surgery department.;Newman;Scand J Infect Dis,2009

4. A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia.;Qin;Int J Antimicrob Agents,2017

5. Efficacy and safety of ceftazidime-avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infection: results from a randomized, controlled, double-blind, phase 3 program.;Mazuski;Clin Infect Dis,2016

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mecanismos moleculares y epidemiología de la resistencia a ceftazidima-avibactam: un análisis integral;Acta Pediátrica de México;2024-07-25

2. Clinical Experience with Ceftazidime/Avibactam for the Treatment of Extensively Drug-Resistant or Pandrug-Resistant Klebsiella pneumoniae in Neonates and Children;2024-07-08

3. Effectiveness of novel β-lactams for Pseudomonas aeruginosa infection: A systematic review and meta-analysis;American Journal of Infection Control;2024-07

4. Ceftazidime–Avibactam Use in a Case Series of Difficult-to-Treat or Recurrent Infections in Pediatric Patients with Complex Chronic Conditions: Effectiveness and Absence of Resistance Development;Antibiotics;2024-06-27

5. Friends or foes? Novel antimicrobials tackling MDR/XDR Gram-negative bacteria: a systematic review;Frontiers in Microbiology;2024-05-10